Tornese et al. reported improvements in T1D management across various Italian pediatric diabetes centers through telemedicine, particularly for patients using insulin pumps, who benefitted from enhanced communication with their healthcare teams via data-sharing platforms [27]. This evidence concerns the gene INS and diabetes mellitus.